Clinical Study
Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?
| | | |
| Age | Median (range) | 62 (45–77) | Gender | Male/female | 49/4 | Primary sites | OP/HP/L | 22/24/7 | T | 1/2/3/4 | 2/18/12/21 | N | 0/1/2a/2b/2c/3 | 6/3/2/9/25/8 | Stage | II/III/IV | 4/3/46 | Chemotherapy regimen | | 30 | | 17 | | 3 | | 3 | RT dose | Median (range) | 70 (60–70) |
|
|
Abbreviations; OP: Oropharynx, HP: Hypopharynx, and L: Larynx.
|